BJDX:NASDAQ, Bluejay Diagnostics, Inc.

Why BJDX stock rose on November 10

Bluejay Diagnostics, Inc. rose 12.9% on Tuesday, November 10, 2026, on 45,700 shares. No headline about BJDX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

BJDX stock overview

Bluejay Diagnostics, Inc. (BJDX:NASDAQ) closed at $2.29 on November 16, 2026, down 12.26% on the day. The stock trades 91.8% below its 52-week high of $28.00 and 24.5% above its 52-week low of $1.84. Over the past year, it lost 90.1%. Bluejay Diagnostics, Inc. is part of the Health Care sector.

Key figures

Price
$2.29
Day change
-12.26%
Volume
6,871
Average volume
328,436
Market cap
2M+
52-week range
$1.84 – $28.00
50-day average
$3.07
200-day average
$6.89

Price action over the past year

In 252 trading sessions since November 14, 2025, BJDX closed higher on 97 days (38%). Its best day was June 2, 2026 (+100.00%) and its worst was June 29, 2026 (-50.85%). The stock moved 10% or more in a single session 26 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

BJDX news

About Bluejay Diagnostics, Inc.

Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide convenience, timeliness, compliance and low cost to physicians and patients in areas where timeliness of the initial triage assessment has a high impact on course of treatment.

Similar stocks

Find more stocks like BJDX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.